Key scientific achievements drive the expansion of the pipeline of molecular glue degraders in fields beyond oncology Evotec ...

Bristol-Myers Squibb (NYSE:BMY – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market ...

Big Pharma is in federal appeals court making the absurd argument that Medicare shouldn’t be able to negotiate drug prices, a ...

Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome ...

Evotec announced in May of 2022 that the Company has further extended and expanded its partnership with Bristol Myers Squibb for another 8 years as the initial collaboration proved to be highly ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

Fintel reports that on October 17, 2024, Bernstein initiated coverage of Bristol-Myers Squibb (NYSE:BMY) with a Market ...

Shares of Bristol Myers Squibb Co. BMY advanced 1.23% to $52.76 Tuesday, on what proved to be an all-around poor trading ...

Bristol-Myers Squibb (BMY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst David Risinger from Leerink Partners maintained a Hold rating on ...

Evotec stock is up following progress in its partnership with Bristol Myers Squibb, including a $50 million payment.

Bristol Myers (BMY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The Bristol Myers Squibb Foundation, an independent charitable organization, has awarded Baylor College of Medicine Global Health $2.25 million for ...